TRFA — TRAFALGAR INTERNATIONAL, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1695473 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -11,555 | 611,378 | 111 | 111 | 12,239 |
| Mar 2026 | 0 | 0 | -33,376 | -33,376 | 1,439 | 1,439 | 776,464 |
| Sep 2025 | 0 | 0 | -37,412 | -36,099 | 21,355 | 21,355 | 1,129,697 |
| Jun 2025 | 0 | 0 | -48,251 | -390,853 | 26,712 | 26,712 | 1,098,955 |
Annual Trend (SEC EDGAR, last 9y)
Revenues vs Net Income (last 9y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -183,005 | -331,612 | 815 | 742,464 | -741,649 | — |
| Dec 2024 | 0 | -156,276 | -179,041 | 57,785 | 898,058 | -840,273 | — |
| Dec 2023 | 0 | -175,364 | -188,402 | 172,276 | 833,508 | -661,232 | — |
| Dec 2022 | 0 | -177,035 | -360,268 | 280,447 | 825,277 | -544,830 | — |
| Dec 2021 | 12,630 | -343,146 | -602,226 | 392,937 | 861,999 | -469,062 | — |
| Dec 2020 | 48,044 | -294,457 | -951,170 | 180,120 | 459,908 | -279,788 | — |
| Dec 2019 | 7,120 | -525,323 | -1,648,595 | 52,662 | 1,599,296 | -1,546,634 | — |
| Dec 2018 | 95,375 | -190,919 | -839,070 | 149,640 | 713,426 | -563,786 | — |
| Dec 2017 | 209 | -646,120 | -793,567 | 993 | 377,973 | -376,980 | — |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$740,754
OpCashFlow TTM
—
Assets (Latest)
$111
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.14T | $1273.46 | — |
| JNJ | JOHNSON & JOHNSON | $635.76B | $263.81 | — |
| ABBV | AbbVie Inc. | $504.76B | $285.64 | — |
| MRK | Merck & Co., Inc. | $358.41B | $145.27 | — |
| NVS | NOVARTIS AG | $287.24B | $151.12 | — |
Recent Insider Activity
No insider activity indexed for this ticker.